TMO Thermo Fisher Scientific Inc
- Stocks
- Healthcare
- NYSE: TMO
Price (delayed)
$463.04
Market cap
$174.85B
P/E Ratio
26.73
Dividend/share
$1.64
EPS
$17.32
Enterprise value
$205.5B
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .
Highlights
The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.1 and 13% less than its last 4 quarters average of 30.7
Thermo Fisher Scientific's quick ratio has increased by 8% from the previous quarter and by 4.4% YoY
The debt has increased by 3% QoQ
Key stats
What are the main financial stats of TMO
Market
Valuations
Earnings
Shares outstanding
377.61M
Market cap
$174.85B
Enterprise value
$205.5B
Price to earnings (P/E)
26.73
Price to book (P/B)
3.46
Price to sales (P/S)
4.05
EV/EBIT
24.46
EV/EBITDA
18.23
EV/Sales
4.76
Revenue
$43.21B
Gross profit
$17.79B
Operating income
$7.41B
Net income
$6.58B
EBIT
$8.4B
EBITDA
$11.27B
Free cash flow
$6.22B
Per share
Balance sheet
Liquidity
EPS
$17.32
EPS diluted
$17.29
Free cash flow per share
$16.46
Book value per share
$133.81
Revenue per share
$114.32
TBVPS
$102.73
Total assets
$101.23B
Total liabilities
$50.75B
Debt
$35.23B
Equity
$50.51B
Working capital
$11.87B
Debt to equity
0.7
Current ratio
1.93
Quick ratio
1.18
Net debt/EBITDA
2.72
Margins
Efficiency
Dividend
EBITDA margin
26.1%
Gross margin
41.2%
Net margin
15.2%
Operating margin
17.1%
Return on assets
6.6%
Return on equity
13.3%
Return on invested capital
15.7%
Return on capital employed
9.5%
Return on sales
19.4%
Dividend yield
0.35%
DPS
$1.64
Payout ratio
9.6%
TMO stock price
How has the Thermo Fisher Scientific stock price performed over time
Intraday
-0.99%
1 week
-3.19%
1 month
9.86%
1 year
-25.53%
YTD
-10.99%
QTD
14.2%
Financial performance
How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$43.21B
Gross profit
$17.79B
Operating income
$7.41B
Net income
$6.58B
Gross margin
41.2%
Net margin
15.2%
Thermo Fisher Scientific's net income has increased by 6% YoY
Thermo Fisher Scientific's gross profit has increased by 3.1% YoY
The net margin has increased by 3.4% YoY
The operating income has grown by 2.9% YoY
Price vs fundamentals
How does TMO's price correlate with its fundamentals
Growth
What is Thermo Fisher Scientific's growth rate over time
Valuation
What is Thermo Fisher Scientific stock price valuation
P/E
26.73
P/B
3.46
P/S
4.05
EV/EBIT
24.46
EV/EBITDA
18.23
EV/Sales
4.76
The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.1 and 13% less than its last 4 quarters average of 30.7
TMO's EPS is up by 7% year-on-year
The P/B is 29% below the 5-year quarterly average of 4.9 and 11% below the last 4 quarters average of 3.9
The company's equity rose by 6% YoY and by 2.3% QoQ
The P/S is 21% below the 5-year quarterly average of 5.1 and 10% below the last 4 quarters average of 4.5
Thermo Fisher Scientific's revenue has increased by 2% YoY
Efficiency
How efficient is Thermo Fisher Scientific business performance
TMO's ROA is up by 3.1% YoY
Dividends
What is TMO's dividend history
DPS
$1.64
Dividend yield
0.35%
Payout ratio
9.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Thermo Fisher Scientific financials performed over time
The total assets is 99% greater than the total liabilities
The current ratio has increased by 12% year-on-year and by 9% since the previous quarter
Thermo Fisher Scientific's quick ratio has increased by 8% from the previous quarter and by 4.4% YoY
The debt is 30% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 7% YoY
The company's equity rose by 6% YoY and by 2.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.